SLC5A2 and diabetes mellitus: However, certain DM medications, such as thiazolidinediones (TZDs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2i), have been implicated in impaired bone formation and altered calcium-phosphate homeostasis, potentially worsening spinal fusion outcomes [13].